Wednesday, July 29, 2020 from 3 to 4 p.m.
|
William G. Adams, MD
BU Director
of Clinical Research Informatics
|
|
The Boston University Clinical and Translational Sciences Institute Biomedical Informatics Core
(BU-BIC) seeks to work with the BU/BMC research community to improve access to and use of clinical data from Boston Medical Center, affiliated Community Health Centers, and other research institutions nationally and internationally. This webinar will provide an update on current data resources, tools and consultation services so that attendees will better understand what is available and how they can be used for research.
|
|
Don't forget to apply for the Early Stage Research Career Development Program. It provides a roadmap and targeted guidance for senior post-doctoral fellows and early career faculty (both MD and PhD) committed to launching an independent research career.
|
|
|
|
The GCRU’s plan is to give priority to existing protocols with minimal inperson contact, followed by already-approved studies of participants with serious and/or short-term health conditions for which study visits cannot be readily deferred.
|
|
|
|
New Funding Opportunities
|
|
 |
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)
Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)
National Institute on Minority Health and Health Disparities (
NIMHD
)
|
International Agency for Research on Cancer (IARC) Monographs Program (R01 Clinical Trial Not Allowed)
National Cancer Institute (
NCI
)
|
Scientific Services to Conduct In-depth Cell Characterization for the NIH Regenerative Medicine Innovation Project 2020
National Heart, Lung, and Blood Institute (
NHLBI
)
|
|
|
|
Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)
Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)
Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases (
NIAID
)
Exploratory Grant Program in Parkinson's Disease Research
(P20- Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke (
NINDS
)
NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional)
|
|
|
|
|
The Biogen Foundation's COVID-19 relief efforts are focused on expanding and ensuring access to testing, easing the burden on healthcare systems and healthcare workers,and providing food and necessities for our most vulnerable populations.
|
|
|
|
|
Due:
July 31, 2020 (LOI)
Funding:
$50,000 to $120,000
Project period:
Not specified
Purpose:
To address the impact of COVID-19 on Medicaid beneficiaries, providers, and delivery innovations at the state level. What successes, gaps, and deficiencies has the pandemic revealed within state Medicaid programs.
|
|
|
|
|
Due:
Every 2 weeks
Funding:
$150,000 to $750,000, depending on study type
Project period:
12 to 24 months, depending on study type
Purpose:
To support promising discovery, preclinical and clinical trial stage projects that could quickly advance treatments to COVID-19 patients in need
.
|
|
|
|
|
|
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
|
The mRNA-1273 vaccine induced anti–SARS-CoV-2 immune responses in all participants, and no trial-limiting safety concerns were identified. These findings support further development of this vaccine.
|
|
|
|
Study in Primates Finds Acquired Immunity Prevents COVID-19 Reinfections
|
Is it possible that people could beat this virus only
to get reinfected a short time later? How long does immunity last after infection? And what can we expect about the duration of protection from a vaccine?
|
|
|
|
Placenta Lacks Major Molecules Used by SARS-CoV-2 Virus to Cause Infection
|
The placental membranes that contain the fetus and amniotic fluid lack the messenger RNA (mRNA) molecule required to manufacture the ACE2 receptor, the main cell surface receptor used by the SARS-CoV-2 virus to cause infection.
|
|
|
|
Interested in Volunteering for a COVID-19 Prevention Clinical Study?
|
Visit the COVID-19 Prevention Network (CoVPN) website to take the questionnaire and join the CoVPN Volunteer Screening Registry.
|
|
|
|
With resources and worldclass scientific talent,
NIH
is in a special position to swiftly mobilize and coordinate the biomedical research response to the
COVID19
pandemic.
|
|
|
|
Observations on Writing Grant Applications - Thursday, July 23, 3:00 p.m. ET
|
One hour-long webinar via
NIGMS
on grant writing includes a 10 to15-minute presentation followed by
a moderated Q&A session.
|
|
|
|
Transforming Translational Science -
Friday, July 24, 2020, 2:00 p.m. ET
|
During this session, participants will learn about
the field of translational science, how NCATS is developing this new field of investigation and opportunities to conduct translational science research in the NCATS intramural laboratories.
|
|
|
|
Healthcare Open Terminology (HOT)
Ecosystem Community Meeting -
Wednesday, August 5, 2020, 1:00 p.m. ET
|
The August HOT Ecosystem Community meeting will feature a presentation on the Human Phenotype Ontology (HPO) and discussion with Peter Robinson, Professor of Computation Biology at the Jackson Laboratory.
|
|
|
|
Boston University Clinical & Translational Science Institute
Accelerating Discoveries Towards Better Health
|
b
u.edu/ctsi | ncats.nih.gov
|
|
|
|
|
|
|
